Bhasker Suman, Biswas Rituparna, Thakar Alok, Chander Subhash, Biswas Ahitagni, Sharma Atul, Halder Anirban, Anne Srikanth, Mohanti Bidhu K
Department of Radiation Oncology, Dr. B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.
Department of Otolaryngology and Rhinology, All India Institute of Medical Sciences, New Delhi, India.
Indian J Surg Oncol. 2020 Sep;11(3):401-405. doi: 10.1007/s13193-020-01062-1. Epub 2020 May 8.
Treatment of maxillary sinus cancer poses several challenges because of its complex anatomy, close proximity to critical structures and majority of patients presenting at an advanced stage. Despite presence of several treatment approaches, the outcome in these cancers has remained dismal. This article examines its clinical behaviour and treatment outcome of these patients treated at our centre in past 7 years. In this retrospective study, 67 patients with carcinoma of maxillary sinus presented from January 2011 to December 2017 were analysed. All the patients reporting during this period were included except those who did not turn up after first visit. Of all the patients, 64.2% had squamous cell carcinoma. The majority of patients presented with advanced stage (IVA and IVB, 83.58%). Nodal disease at presentation was seen in seven patients (10.4%). Treatment to the primary site comprised of surgery and radiotherapy in 24 patients, radiotherapy alone in 22 patients and surgery alone in 12 patients. Statistical program for social sciences (SPSS) version 16 was used for all statistical analyses. The mean follow-up time was 25 months (range 3-72 months). Overall, 17 out of 41 patients who were treated with curative intent (41.5%) developed recurrence. Patients who underwent surgery followed by adjuvant radiotherapy did fairly better in terms of recurrence. Seven patients out of 17 (41.2%) could be salvaged by surgery or radiation. Only one patient developed distant metastasis to D8 vertebra. Patients who were treated with surgery and radiotherapy (either preoperative/adjuvant setting) had better disease-free survival. The results of the current study regarding the treatment of carcinoma of the maxillary sinus show feasibility and efficacy of multimodal therapy. Radical radiotherapy appears to be a feasible alternative in cases of inoperable tumours. Loco regional relapse remains a significant pattern of failure.
由于上颌窦癌解剖结构复杂、紧邻关键结构且大多数患者就诊时已处于晚期,其治疗面临诸多挑战。尽管存在多种治疗方法,但这些癌症的治疗效果仍然不佳。本文探讨了过去7年在我们中心接受治疗的这些患者的临床行为和治疗结果。在这项回顾性研究中,分析了2011年1月至2017年12月期间就诊的67例上颌窦癌患者。在此期间报告的所有患者均被纳入,但首次就诊后未再来的患者除外。所有患者中,64.2%为鳞状细胞癌。大多数患者就诊时处于晚期(IVA和IVB期,83.58%)。7例患者(10.4%)就诊时出现淋巴结转移。对原发部位的治疗包括24例患者接受手术和放疗,22例患者仅接受放疗,12例患者仅接受手术。所有统计分析均使用社会科学统计软件包(SPSS)版本16。平均随访时间为25个月(范围3 - 72个月)。总体而言,41例接受根治性治疗的患者中有17例(41.5%)复发。接受手术加辅助放疗的患者在复发方面表现较好。17例患者中有7例(41.2%)可通过手术或放疗挽救。仅1例患者发生远处转移至D8椎体。接受手术和放疗(术前/辅助治疗)的患者无病生存期较好。当前关于上颌窦癌治疗的研究结果显示了多模式治疗的可行性和有效性。对于无法手术的肿瘤,根治性放疗似乎是一种可行的替代方案。局部区域复发仍然是一个重要的失败模式。